Zevor-Cel therapy
Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
multiple-myeloma-immunotherapy
Introduction
In the ever-evolving realm of oncological treatment, scientists persistently seek out unconventional targets that can amplify the effectiveness of interventions while mitigating unwanted...
multiple-myeloma-immunotherapy
Discover how immunotherapy can be your true friend in beating myeloma! Our blog provides simple insights into the power of immunotherapy for multiple myeloma. Don't miss out on this resource for a mo...
multiple-myeloma-immunotherapy
multiple-myeloma-immunotherapy